Reprint
Nutrition, Microbiota and Noncommunicable Diseases
Edited by
August 2020
416 pages
- ISBN978-3-03936-916-4 (Hardback)
- ISBN978-3-03936-917-1 (PDF)
This is a Reprint of the Special Issue Nutrition, Microbiota and Noncommunicable Diseases that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
Health is defined as “the state of the organism when it functions optimally without evidence of disease”. Surprisingly, the words “microbes” or “microorganism” are missing in this definition. The regulation of gut microbiota is mediated by an enormous quantity of aspects, such as microbiological factors, host characteristics, diet patterns, and environmental variables. Some protective, structural, and metabolic functions have been reported for gut microbiota, and these functions are related to the regulation of homeostasis and host health. Host defense against pathogens is, in part, mediated through gut microbiota action and requires intimate interpretation of the current microenvironment and discrimination between commensal and occasional bacteria. The present Special Issue provides a summary of the progress on the topic of intestinal microbiota and its important role in human health in different populations. This Special Issue will be of great interest from a clinical and public health perspective. Nevertheless, more studies with more samples and comparable methods are necessary to understand the actual function of intestinal microbiota in disease development and health maintenance.
Format
- Hardback
License and Copyright
© 2020 by the authors; CC BY-NC-ND license
Keywords
sperm quality; probiotics; zebrafish; motility; behavior; intestinal microbiota; intestinal Bacteroides; cardiorespiratory fitness; trunk muscle training; aerobic exercise training; brisk walking; intestinal microbiota; probiotics; nutrients; gut microbiota; nutrition; habitual diets; Western diet; obesity; cardiometabolic risk factors; chronic health conditions; gastrointestinal disorders; prebiotics and probiotics; metabolic syndrome; gastrointestinal microbiome; Lactobacillus reuteri V3401; probiotics; obesity; sugar alcohol; prebiotic; bowel function; immune function; respiratory tract infections; otitis media; sinusitis; weight management; satiety; bone health; AMP-activated protein kinase; butyrate; developmental origins of health and disease (DOHaD); gut microbiota; high fat diet; hypertension; nutrient-sensing signals; propionate; short chain fatty acids; kefir; gut microbiota; metabolic syndrome; autism spectrum disorders; gut microbiota; oral microbiota; dysbiosis; co-occurring conditions; allergy; abdominal pain; biomarker discovery; anorexia; food restriction; ClpB; microbiota; Enterobacteriaceae; microbiota; inulin; circadian rhythm; feeding timing; choline; trimethylamine; trimethylamine n-oxide; 16S rRNA gene profiling; qPCR; linear mixed models; soy protein; microbiota; lipid metabolism; circadian; chrono-nutrition; microbiome; pregnancy; fetus; placenta; newborn; infancy; critical illness; sepsis; allergy; lipid metabolome; amlodipine; probiotics; corticosterone; ACTH; gut bacteriome; ischemia-reperfusion injury; nutritional status; supplemented nutrition; gut microbiota; partial hepatectomy; liver transplantation; vaginal microbiome; bacterial communities; vaginal dysbiosis; bacterial vaginosis; risk factors; nutrition; probiotics; hormone replacement therapy; cardiovascular diseases; atherosclerosis; gut microbiota; microbiome; prebiotics; alanine aminotransferase; antibiotic; Optifast; gut microbiome; inulin; metronidazole; nonnutritive sweeteners; sweetening agents; gut microbiota; n/a